NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorCedars-Sinai Medical Center
About this trial
In this pilot study, the investigators will show feasibility of the NLP-based feedback system in 20 consultations of men with newly diagnosed prostate cancer. The investigators will recruit from the practices of up to 10 physicians who typically see these patients. The investigators will report the top five sentences from each consultation across key content areas (cancer prognosis, life expectancy, erectile dysfunction, urinary incontinence, and irritative urinary symptoms) to both patients and physicians within 2 weeks of the consultation.
Eligibility criteria
Qualifiers
Men undergoing initial treatment consultation for clinically localized prostate cancer;
Men with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy.
Cedars-Sinai patient.
Ability to read and write in English.
Disqualifiers
Under 18 years of age;
Subjects with difficulty communicating or dementia;
Non-English speakers, given that our NLP-based tools cannot be used with languages other than English;
Men with locally advanced or metastatic prostate cancer;
Trial design
Treatments tested in this trial
- NLP-based Feedback
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Cedars-Sinai Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov